SG11201406518XA - Substituted benzamides and their uses - Google Patents
Substituted benzamides and their usesInfo
- Publication number
- SG11201406518XA SG11201406518XA SG11201406518XA SG11201406518XA SG11201406518XA SG 11201406518X A SG11201406518X A SG 11201406518XA SG 11201406518X A SG11201406518X A SG 11201406518XA SG 11201406518X A SG11201406518X A SG 11201406518XA SG 11201406518X A SG11201406518X A SG 11201406518XA
- Authority
- SG
- Singapore
- Prior art keywords
- substituted benzamides
- benzamides
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261623517P | 2012-04-12 | 2012-04-12 | |
| US201361791823P | 2013-03-15 | 2013-03-15 | |
| PCT/US2013/036229 WO2013155338A2 (en) | 2012-04-12 | 2013-04-11 | Substituted benzamides and their uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201406518XA true SG11201406518XA (en) | 2014-11-27 |
Family
ID=49328285
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406518XA SG11201406518XA (en) | 2012-04-12 | 2013-04-11 | Substituted benzamides and their uses |
| SG10201509063SA SG10201509063SA (en) | 2012-04-12 | 2013-04-11 | Substituted benzamides and their uses |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201509063SA SG10201509063SA (en) | 2012-04-12 | 2013-04-11 | Substituted benzamides and their uses |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9296732B2 (zh) |
| EP (1) | EP2838534A4 (zh) |
| JP (1) | JP2015516393A (zh) |
| KR (1) | KR20150013475A (zh) |
| CN (1) | CN104411311A (zh) |
| AU (1) | AU2013245809A1 (zh) |
| CA (1) | CA2873701A1 (zh) |
| HK (1) | HK1207301A1 (zh) |
| IL (1) | IL235145A0 (zh) |
| MX (1) | MX2014012294A (zh) |
| RU (1) | RU2014141510A (zh) |
| SG (2) | SG11201406518XA (zh) |
| WO (1) | WO2013155338A2 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012051117A2 (en) * | 2010-10-11 | 2012-04-19 | The Board Of Trustees Of The Leland Stanford Junior University | Substituted benzamides and their uses |
| WO2015078799A1 (en) * | 2013-11-27 | 2015-06-04 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| ES2838573T3 (es) | 2014-08-21 | 2021-07-02 | Bristol Myers Squibb Co | Derivados de benzamida ligados como inhibidores potentes de ROCK |
| WO2016202935A1 (en) | 2015-06-19 | 2016-12-22 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| CA3166630A1 (en) | 2020-01-03 | 2021-07-08 | Berg Llc | Polycyclic amides as ube2k modulators for treating cancer |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| ES2293638T3 (es) | 1994-03-25 | 2008-03-16 | Isotechnika, Inc. | Mejora de la eficacia de farmacos por deuteracion. |
| US6110973A (en) | 1998-01-29 | 2000-08-29 | Sepracor | Methods for treating obesity and weight gain using optically pure (-)-bupropion |
| TW200404789A (en) | 1999-03-15 | 2004-04-01 | Axys Pharm Inc | Novel compounds and compositions as protease inhibitors |
| US6835731B2 (en) * | 2000-09-15 | 2004-12-28 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| EP1369420A1 (en) | 2002-06-06 | 2003-12-10 | Aventis Pharma Deutschland GmbH | Inhibitors of the GPib - vWF interaction |
| US7235558B2 (en) | 2002-06-06 | 2007-06-26 | Sanofi-Aventis Deutschland Gmbh | Inhibitors of the GPIb—vWF interaction, their preparation and use |
| TW200505446A (en) | 2003-01-17 | 2005-02-16 | Fuj Isawa Pharmaceutical Co Ltd | Inhibitor of cox |
| US20080293711A1 (en) | 2007-03-08 | 2008-11-27 | Clark Michael P | Chemokine receptor modulators |
| US8252823B2 (en) * | 2008-01-28 | 2012-08-28 | New York University | Oxazole and thiazole compounds as beta-catenin modulators and uses thereof |
| US20110105436A1 (en) | 2008-03-10 | 2011-05-05 | Auckland Uniservices Limited | Heteroaryl compounds, compositions, and methods of use in cancer treatment |
| PT3135672T (pt) * | 2008-10-10 | 2020-04-02 | Vm Discovery Inc | Composições e métodos para o tratamento distúrbios de utilização de álcool, dor e outras doenças |
| US20120040951A1 (en) | 2008-12-30 | 2012-02-16 | Claudio Chuaqui | Heteroaryl compounds useful as raf kinase inhibitors |
| ES2547072T3 (es) * | 2009-07-21 | 2015-10-01 | The Board Of Trustees Of The Leland Stanford Junior University | Heteroaril benzamidas, composiciones y métodos de utilización |
| WO2012051117A2 (en) | 2010-10-11 | 2012-04-19 | The Board Of Trustees Of The Leland Stanford Junior University | Substituted benzamides and their uses |
| US9079859B2 (en) | 2011-01-21 | 2015-07-14 | Auckland Uniservices Limited | Synthetic lethal targeting of glucose transport |
-
2013
- 2013-04-11 MX MX2014012294A patent/MX2014012294A/es unknown
- 2013-04-11 WO PCT/US2013/036229 patent/WO2013155338A2/en active Application Filing
- 2013-04-11 SG SG11201406518XA patent/SG11201406518XA/en unknown
- 2013-04-11 JP JP2015505920A patent/JP2015516393A/ja active Pending
- 2013-04-11 US US14/391,690 patent/US9296732B2/en not_active Expired - Fee Related
- 2013-04-11 CA CA2873701A patent/CA2873701A1/en not_active Abandoned
- 2013-04-11 KR KR1020147030024A patent/KR20150013475A/ko not_active Application Discontinuation
- 2013-04-11 AU AU2013245809A patent/AU2013245809A1/en not_active Abandoned
- 2013-04-11 EP EP13776347.0A patent/EP2838534A4/en not_active Withdrawn
- 2013-04-11 RU RU2014141510A patent/RU2014141510A/ru not_active Application Discontinuation
- 2013-04-11 SG SG10201509063SA patent/SG10201509063SA/en unknown
- 2013-04-11 CN CN201380028852.5A patent/CN104411311A/zh active Pending
-
2014
- 2014-10-19 IL IL235145A patent/IL235145A0/en unknown
-
2015
- 2015-08-18 HK HK15107945.4A patent/HK1207301A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150013475A (ko) | 2015-02-05 |
| CN104411311A (zh) | 2015-03-11 |
| US9296732B2 (en) | 2016-03-29 |
| CA2873701A1 (en) | 2013-10-17 |
| HK1207301A1 (zh) | 2016-01-29 |
| US20150072976A1 (en) | 2015-03-12 |
| RU2014141510A (ru) | 2016-06-10 |
| MX2014012294A (es) | 2015-06-05 |
| JP2015516393A (ja) | 2015-06-11 |
| AU2013245809A1 (en) | 2014-11-06 |
| EP2838534A2 (en) | 2015-02-25 |
| SG10201509063SA (en) | 2015-12-30 |
| EP2838534A4 (en) | 2015-11-11 |
| IL235145A0 (en) | 2014-12-31 |
| WO2013155338A3 (en) | 2013-12-27 |
| WO2013155338A2 (en) | 2013-10-17 |
| WO2013155338A8 (en) | 2015-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1199023A1 (zh) | 取代的苯並噻吩基-吡咯並三嗪及其用途 | |
| HK1202545A1 (zh) | 新型二氮雜螺環烷烴和氮雜螺環烷烴 | |
| HK1203493A1 (zh) | 取代的氮雜雙環及其用途 | |
| HK1200822A1 (zh) | 取代的聯吡啶胺及其用途 | |
| HK1210949A1 (zh) | 組合及其用途 | |
| HK1214242A1 (zh) | 苯甲酰胺 | |
| HK1203198A1 (zh) | 取代的苯基咪唑並吡唑及其用途 | |
| HK1207301A1 (zh) | 取代的苯甲酰胺及其用途 | |
| HK1210809A1 (zh) | β己糖基轉移酶及其用法 | |
| PL2830587T3 (pl) | Kompozycja o balansującym i ochronnym wpływie na skórę | |
| GB201222541D0 (en) | Kiddibidet and pottibidet | |
| IL218974A0 (en) | Conaction bitwen coutch and playels | |
| GB201202021D0 (en) | Co-sleeper and breastfeeder | |
| GB201214749D0 (en) | Compounds and their uses | |
| GB201213726D0 (en) | Novel compounds and their use |